Skip to main content

Published locations for ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk

User login

  • Reset your password
  • /content/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes-high-cvd-risk
  • /clinicianreviews/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes
  • /familypracticenews/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes
  • /fedprac/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes-high-cvd
  • /internalmedicinenews/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1
  • /clinicalendocrinologynews/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1
  • /ecardiologynews/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes
  • /cardiology/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes-high-cvd
  • /endocrinology/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes-high
  • /internalmedicine/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes
  • /familymedicine/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1-diabetes-high
  • /type-2-diabetes-icymi/article/265011/cad-atherosclerosis/esc-backs-sglt2-inhibitor-plus-glp-1